Bio-Techne – Where Science Intersects Innovation | bio-techne.com



Bio-Techne – Where Science Intersects Innovation

BioTechne empowers researchers by providing high-quality reagents, instruments, custom manufacturing, and testing services with our family of brands.

COMPANY PROFILE

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions – notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.

Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx® Prostate test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment.

Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 Billion in net sales in fiscal 2022 and has approximately 3,000 employees worldwide.

 

CONTACT INFORMATION

Investor Relations
David Clair
T: 612-656-4416
ir@bio-techne.com

Company Contact
Bio-Techne Corporation
614 McKinley Place NE
Minneapolis, MN 55413


©Copyright 2023.All Rights Reserved.

Disclaimer : This advertisement and the information related to it are provided and maintained by the advertiser. Atipes.com is not responsible and can not guarantee the accuracy or completeness of this advertisement. Please note that every advertisement for rent or for sale should at a minimum, display the energy performance rating of the property. See our Flats and Housing Posting Rules for more information.

Avoid scams: Signs of fraud: wire transfer, money orders, cashier checks, payment via gift cards, shipping, escrow, "transaction protection", "guarantee". Be safe by dealing locally.

bio-techne.jpg

Scroll to Top